DNA repair inhibition and cancer therapy.

[1]  M. Mark,et al.  Loss of poly(ADP‐ribose) polymerase‐1 causes increased tumour latency in p53‐deficient mice , 2001, The EMBO journal.

[2]  Z. Herceg,et al.  Functions of poly(ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity and cell death. , 2001, Mutation research.

[3]  M. Blagosklonny,et al.  Exploiting cancer cell cycling for selective protection of normal cells. , 2001, Cancer research.

[4]  David E. Williams,et al.  Inhibition of the G2 DNA Damage Checkpoint and of Protein Kinases Chk1 and Chk2 by the Marine Sponge Alkaloid Debromohymenialdisine* , 2001, The Journal of Biological Chemistry.

[5]  J. Hoeijmakers.  Genome maintenance mechanisms for preventing cancer , 2001, Nature.

[6]  K Jarnagin,et al.  Novel inhibitors of poly(ADP-ribose) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast. , 2001, Cancer research.

[7]  P. Kiberstis.  Cancer Therapy on Target , 2001, Science.

[8]  E. Sausville,et al.  Phase I trial of 72-hour continuous infusion UCN-01 in patients with refractory neoplasms. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  D. Durocher,et al.  DNA-PK, ATM and ATR as sensors of DNA damage: variations on a theme? , 2001, Current opinion in cell biology.

[10]  K. Khanna,et al.  DNA double-strand breaks: signaling, repair and the cancer connection , 2001, Nature Genetics.

[11]  S. Smith,et al.  The world according to PARP. , 2001, Trends in biochemical sciences.

[12]  H. Blattmann,et al.  Wortmannin selectively enhances radiation-induced apoptosis in proliferative but not quiescent cells. , 2001, International journal of radiation oncology, biology, physics.

[13]  S. Elledge,et al.  The DNA damage response: putting checkpoints in perspective , 2000, Nature.

[14]  Roger L. Williams,et al.  Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. , 2000, Molecular cell.

[15]  N. Walworth,et al.  The G2-phase DNA-damage checkpoint. , 2000, Trends in cell biology.

[16]  N. Curtin,et al.  Potentiation of temozolomide and topotecan growth inhibition and cytotoxicity by novel poly(adenosine diphosphoribose) polymerase inhibitors in a panel of human tumor cell lines. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[17]  J. Sarkaria,et al.  The radiosensitizing agent 7-hydroxystaurosporine (UCN-01) inhibits the DNA damage checkpoint kinase hChk1. , 2000, Cancer research.

[18]  R. Wood,et al.  Damage recognition in nucleotide excision repair of DNA. , 2000, Gene.

[19]  Y. Shiloh,et al.  Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Elledge,et al.  Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. , 1999, Science.

[21]  A New Way to Combat Therapy Side Effects , 1999, Science.

[22]  J. Sarkaria,et al.  Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. , 1999, Cancer research.

[23]  F. Apiou,et al.  PARP-2, A Novel Mammalian DNA Damage-dependent Poly(ADP-ribose) Polymerase* , 1999, The Journal of Biological Chemistry.

[24]  S. Jackson,et al.  Competitive and noncompetitive inhibition of the DNA-dependent protein kinase. , 1999, Cancer research.

[25]  R. Kornberg,et al.  Structure of DNA‐dependent protein kinase: implications for its regulation by DNA , 1999, The EMBO journal.

[26]  G. de Murcia,et al.  Importance of Poly(ADP-ribose) Polymerase and Its Cleavage in Apoptosis , 1998, The Journal of Biological Chemistry.

[27]  N. Curtin,et al.  Resistance-modifying agents. 5. Synthesis and biological properties of quinazolinone inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase (PARP). , 1998, Journal of medicinal chemistry.

[28]  Y. Hosoi,et al.  A phosphatidylinositol 3‐kinase inhibitor wortmannin induces radioresistant DNA synthesis and sensitizes cells to bleomycin and ionizing radiation , 1998, International journal of cancer.

[29]  M M Haglund,et al.  Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  J. Sarkaria,et al.  Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin. , 1998, Cancer research.

[31]  Y Taya,et al.  Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. , 1998, Science.

[32]  T. Weinert.  DNA Damage and Checkpoint Pathways Molecular Anatomy and Interactions with Repair , 1998, Cell.

[33]  Y. Shiloh,et al.  ATM: from gene to function. , 1998, Human molecular genetics.

[34]  F. Alt,et al.  A targeted DNA-PKcs-null mutation reveals DNA-PK-independent functions for KU in V(D)J recombination. , 1998, Immunity.

[35]  M. Malanga,et al.  Poly(ADP-ribose) Binds to Specific Domains of p53 and Alters Its DNA Binding Functions* , 1998, The Journal of Biological Chemistry.

[36]  P. Frit,et al.  UV sensitivity and impaired nucleotide excision repair in DNA-dependent protein kinase mutant cells. , 1998, Nucleic acids research.

[37]  P. Nurse.  Checkpoint Pathways Come of Age , 1997, Cell.

[38]  J. Tainer,et al.  Base excision repair enzyme family portrait: integrating the structure and chemistry of an entire DNA repair pathway. , 1997, Structure.

[39]  P. Chambon,et al.  Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[40]  K. Rosenzweig,et al.  Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[41]  P. Jeggo.  DNA-PK: at the cross-roads of biochemistry and genetics. , 1997, Mutation research.

[42]  T. Saito,et al.  Nonsense mutation at Tyr-4046 in the DNA-dependent protein kinase catalytic subunit of severe combined immune deficiency mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M. Lieber,et al.  Tying loose ends: roles of Ku and DNA-dependent protein kinase in the repair of double-strand breaks. , 1997, Current opinion in genetics & development.

[44]  S. Boulton,et al.  Wortmannin is a potent inhibitor of DNA double strand break but not single strand break repair in Chinese hamster ovary cells. , 1996, Carcinogenesis.

[45]  D. Sidransky,et al.  Selective radiosensitization of p53–deficient cells by caffeine–mediated activation of p34cdc2 kinase , 1996, Nature Medicine.

[46]  J. Danska,et al.  Biochemical and genetic defects in the DNA-dependent protein kinase in murine scid lymphocytes , 1996, Molecular and cellular biology.

[47]  G. Schulz,et al.  Structure of the catalytic fragment of poly(AD-ribose) polymerase from chicken. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Francis Collins,et al.  Atm-Deficient Mice: A Paradigm of Ataxia Telangiectasia , 1996, Cell.

[49]  J. Węsierska‐Gądek,et al.  ADP‐ribosylation of p53 tumor suppressor protein: Mutant but not wild‐type p53 is modified , 1996, Journal of cellular biochemistry.

[50]  J. Takahara,et al.  UCN-01, 7-hydroxyl-staurosporine, inhibits kinase activity of cyclin-dependent kinases and reduces the phosphorylation of the retinoblastoma susceptibility gene product in A549 human lung cancer cell line. , 1996, Biochemical and biophysical research communications.

[51]  B. Price,et al.  The phosphatidylinositol 3-kinase inhibitor wortmannin sensitizes murine fibroblasts and human tumor cells to radiation and blocks induction of p53 following DNA damage. , 1996, Cancer research.

[52]  S. Friend,et al.  Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay. , 1995, Cancer research.

[53]  M. Groudine,et al.  Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells. , 1995, Cancer research.

[54]  F. Alt,et al.  Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation , 1995, Cell.

[55]  L. Hartwell,et al.  Cell cycle control and cancer. , 1994, Science.

[56]  D. Fisher.  Apoptosis in cancer therapy: Crossing the threshold , 1994, Cell.

[57]  K Y Hui,et al.  A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). , 1994, The Journal of biological chemistry.

[58]  S. Seeber,et al.  Chemosensitisation of alkylating agents by pentoxifylline, O6-benzylguanine and ethacrynic acid in haematological malignancies. , 1993, Anticancer research.

[59]  S. Jackson,et al.  The DNA-dependent protein kinase: Requirement for DNA ends and association with Ku antigen , 1993, Cell.

[60]  B. Vogelstein,et al.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia , 1992, Cell.

[61]  J. Sebolt-Leopold,et al.  Dihydroisoquinolinones: the design and synthesis of a new series of potent inhibitors of poly(ADP-ribose) polymerase. , 1991, Anti-cancer drug design.

[62]  M. Dolan,et al.  Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[63]  T. Kato,et al.  Enhancement of bleomycin activity by 3-aminobenzamide, a poly (ADP-ribose) synthesis inhibitor, in vitro and in vivo. , 1988, Anticancer research.

[64]  W. Haseltine,et al.  Distribution of UV light-induced damage in a defined sequence of human DNA: detection of alkaline-sensitive lesions at pyrimidine nucleoside-cytidine sequences. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[65]  R. Painter,et al.  Radiosensitivity in ataxia-telangiectasia: a new explanation. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[66]  M. R. Purnell,et al.  Novel inhibitors of poly(ADP-ribose) synthetase. , 1980, The Biochemical journal.

[67]  R. W. Jones,et al.  The action of caffeine on X-irradiated HeLa cells. I. Delayed inhibition of DNA synthesis. , 1977, Radiation research.

[68]  G. Hannon,et al.  RNA interference , 2002, Nature.

[69]  T. Sugimura,et al.  Increased susceptibility of poly(ADP-ribose) polymerase-1 knockout mice to nitrosamine carcinogenicity. , 2001, Carcinogenesis.

[70]  Bruce A.J. Ponder,et al.  Cancer genetics , 2001, Nature.

[71]  A. Lehmann,et al.  The xeroderma pigmentosum group D (XPD) gene: one gene, two functions, three diseases. , 2001, Genes & development.

[72]  S. Shall,et al.  From DNA damage and stress signalling to cell death : poly-ADP-ribosylation reactions , 2000 .

[73]  J. H. Kim,et al.  4-Amino-1,8-naphthalimide: a novel inhibitor of poly(ADP-ribose) polymerase and radiation sensitizer. , 1999, International journal of radiation biology.

[74]  J. Cadet,et al.  Oxidative damage to DNA: formation, measurement, and biological significance. , 1997, Reviews of physiology, biochemistry and pharmacology.

[75]  S. Jackson,et al.  DNA damage detection by DNA dependent protein kinase and related enzymes. , 1996, Cancer surveys.

[76]  A. Sancar.  DNA repair in humans. , 1995, Annual review of genetics.

[77]  W. Leopold,et al.  Chemical Approaches to Improved Radiotherapy , 1992 .

[78]  C. Petrou,et al.  Effects of alkylating antineoplastics alone or in combination with 3-aminobenzamide on genotoxicity, antitumor activity, and NAD levels in human lymphocytes in vitro and on Ehrlich ascites tumor cells in vivo. , 1990, Teratogenesis, carcinogenesis, and mutagenesis.

[79]  E. Jacobson,et al.  ADP-ribose transfer reactions : mechanisms and biological significance , 1989 .